New work from Ron Crystal's lab on treating hereditary adrenal disorders

New work from Ron Crystal's lab on treating hereditary adrenal disorders
Credit: Mary Ann Liebert, Inc., publishers

A new study has definitively shown that a single treatment with gene therapy using adeno-associated viral (AAV) vector gene delivery to replace the defective gene responsible for congenital adrenal hyperplasia (CAH) will only temporarily alleviate the hereditary disorder. The normal cells will eventually be replaced by new adrenocortical cells carrying the disease mutation, and a long-term solution will require targeting the genetic mutation carried in a patient's adrenocortical stem cells, as reported in an article published in Human Gene Therapy.

Sandra Markmann, Ronald Crystal, and a team of researchers from Weill Cornell Medical College, New York, NY coauthored the article entitled "Biology of the Adrenal Gland Coretex Obviates Effective Use of Adeno-Associated Virus Vectors to Treat Hereditary Adrenal Disorders ." The researchers demonstrated that the loss over time of therapeutic genes delivered by AAV vectors was not due to an immune response against the AAV delivery vehicles and was instead a result of the renewal of adrenocortical stem cell populations.

"There has been a growing trend in gene therapy to target diseases identified by newborn screening. CAH screening has been included in the U.S. for decades, with corticosteroid replacement being the only therapy," says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA. "Defining the limitations to AAV gene therapy in such disorders is an important step, much as was the early work in cystic fibrosis. Such studies, even though they show limitations, move us closer to identifying the right solution for these patients."


Explore further

Mini form of replacement gene can delay degeneration in leber congenital amaurosis

More information: Sandra Markmann et al, Biology of the Adrenal Gland Cortex Obviates Effective Use of Adeno-Associated Virus Vectors to Treat Hereditary Adrenal Disorders, Human Gene Therapy (2018). DOI: 10.1089/hum.2017.203
Journal information: Human Gene Therapy

Citation: New work from Ron Crystal's lab on treating hereditary adrenal disorders (2018, March 29) retrieved 17 November 2019 from https://medicalxpress.com/news/2018-03-ron-crystal-lab-hereditary-adrenal.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments